Crossmark

Glutamine‐utilizing transaminases are a metabolic vulnerability of TAZ/YAP‐activated cancer cells

Published Online: 2018-04-16

Published Print: 2018-06

Authors

Yang, Chih‐Sheng

Stampouloglou, Eleni

Kingston, Nathan M

Zhang, Liye

Monti, Stefano

Varelas, Xaralabos https://orcid.org/0000-0002-2882-4541
Funding

Funding for this research was provided by:

Susan G. Komen (GTDR15331228)

Congressionally Directed Medical Research Programs (W81XWH‐14‐1‐0336)

National Heart, Lung, and Blood Institute (R01HL124392)

National Center for Advancing Translational Sciences (TL1 TR001410)

National Center for Advancing Translational Sciences (T32 HL007035‐40)
License Information

Accepted Manuscript valid from 2019-04-16

Version of Record valid from 2018-04-16
More Information

Publication History

Received: 2016-10-26

Accepted: 2018-03-23

Published: 2018-04-16

Document is current